Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New treatment option now available for type II diabetics in the U.K.

Oct. 16, 1998

Phase I trials to begin with vomeropherin compound for PMS

Oct. 15, 1998

Pharming and Genzyme form joint venture to develop enzyme for Pompe's disease

Oct. 15, 1998

U.K. launch announced for Evista

Oct. 15, 1998

Japanese laboratory synthesizes new antidiabetic agents

Oct. 15, 1998

Another market introduction for Novartis bisphosphonate

Oct. 14, 1998

Oralin cleared for phase III trials in Ecuador; regulatory clearance expected by year-end

Oct. 13, 1998

Scientists report significant finding related to the genetics of insulin-dependent diabetes

Oct. 13, 1998

Rhone-Poulenc Rorer's Estalis approved in 12 E.U. countries

Oct. 13, 1998

Early clinical study results published for Organon antiprogestagen

Oct. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...